Taming the Morning Surge: A QbD-Engineered Multiparticulate Capsule for Sequential RAAS and β₁-Blockade in Circadian Hypertension

Abstract Purpose: Morning blood pressure surge increases cardiovascular risk due to circadian activation of the renin–angiotensin–aldosterone and sympathetic nervous systems. This study developed a Quality by Design (QbD)-based dual-release multiparticulate capsule providing immediate release of olmesartan medoxomil followed by pH-responsive delayed release of metoprolol succinate for chronotherapeutic management of circadian hypertension. Methods: Immediate and delayed-release pellets were prepared by extrusion-spheronization and optimized using Response Surface Methodology with a Box-Behnken Design. Critical formulation variables were optimized to maximize entrapment efficiency, production yield, and drug release. Optimized formulations were evaluated by FTIR, SEM, dissolution studies, release kinetics, and accelerated stability testing. Results: Optimized formulations showed excellent agreement with the quadratic models (R² = 0.9915–0.9988; p < 0.0001). Immediate-release olmesartan pellets provided rapid drug release, while Eudragit-coated metoprolol pellets minimized gastric release and achieved controlled intestinal release. The optimized capsule exhibited satisfactory physicochemical properties, high content uniformity, low friability, reproducible sequential drug release, and acceptable accelerated stability. Conclusion: The QbD-based multiparticulate system successfully combined immediate and delayed drug release in a single chronotherapeutic dosage form. The optimized formulation established a robust design space and demonstrated the potential of sequential multiparticulate delivery for improving management of the early morning hypertension surge.

Authors

Institutions

Publication Details

Journal
BioNanoScience
Published
2026-11-16
DOI
https://doi.org/10.1007/s12668-026-02965-z
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Taming the Morning Surge: A QbD-Engineered Multiparticulate Capsule for Sequential RAAS and β₁-Blockade in Circadian Hypertension

Suriya Prakaash Kannan, Damodharan Narayanasamy, Gokul Haribut
BioNanoScience
Advanced Drug Delivery Systems
article

Taming the Morning Surge: A QbD-Engineered Multiparticulate Capsule for Sequential RAAS and β₁-Blockade in Circadian Hypertension

Suriya Prakaash Kannan, Damodharan Narayanasamy, Gokul Haribut
article en

Abstract

Abstract Purpose: Morning blood pressure surge increases cardiovascular risk due to circadian activation of the renin–angiotensin–aldosterone and sympathetic nervous systems. This study developed a Quality by Design (QbD)-based dual-release multiparticulate capsule providing immediate release of olmesartan medoxomil followed by pH-responsive delayed release of metoprolol succinate for chronotherapeutic management of circadian hypertension. Methods: Immediate and delayed-release pellets were prepared by extrusion-spheronization and optimized using Response Surface Methodology with a Box-Behnken Design. Critical formulation variables were optimized to maximize entrapment efficiency, production yield, and drug release. Optimized formulations were evaluated by FTIR, SEM, dissolution studies, release kinetics, and accelerated stability testing. Results: Optimized formulations showed excellent agreement with the quadratic models (R² = 0.9915–0.9988; p < 0.0001). Immediate-release olmesartan pellets provided rapid drug release, while Eudragit-coated metoprolol pellets minimized gastric release and achieved controlled intestinal release. The optimized capsule exhibited satisfactory physicochemical properties, high content uniformity, low friability, reproducible sequential drug release, and acceptable accelerated stability. Conclusion: The QbD-based multiparticulate system successfully combined immediate and delayed drug release in a single chronotherapeutic dosage form. The optimized formulation established a robust design space and demonstrated the potential of sequential multiparticulate delivery for improving management of the early morning hypertension surge.

BioNanoScienceVol. 16(12)
SRM Institute of Science and Technology (IN)
SRM Institute of Science and Technology
Good health and well-being
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon